Analysts: Momenta Pharmaceuticals Inc (MNTA.OQ)
MNTA.OQ on NASDAQ Stock Exchange Global Select Market
16.53USD
1 Aug 2013
16.53USD
1 Aug 2013
Price Change (% chg)
$-0.73 (-4.23%)
$-0.73 (-4.23%)
Prev Close
$17.26
$17.26
Open
$16.78
$16.78
Day's High
$16.95
$16.95
Day's Low
$16.48
$16.48
Volume
233,326
233,326
Avg. Vol
137,075
137,075
52-wk High
$18.02
$18.02
52-wk Low
$10.05
$10.05
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.46 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 4 | 3 | 2 | 2 |
| (2) OUTPERFORM | 1 | 1 | 0 | 0 |
| (3) HOLD | 1 | 2 | 3 | 3 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.86 | 2.14 | 2.50 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 6 | 8.59 | 12.00 | 6.91 | -- |
| Quarter Ending Dec-13 | 6 | 8.40 | 11.00 | 6.90 | -- |
| Year Ending Dec-13 | 7 | 32.81 | 42.60 | 28.75 | 67.50 |
| Year Ending Dec-14 | 7 | 145.75 | 289.00 | 18.99 | 66.09 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 7 | -0.46 | -0.43 | -0.55 | -- |
| Quarter Ending Dec-13 | 7 | -0.46 | -0.39 | -0.57 | -- |
| Year Ending Dec-13 | 8 | -1.88 | -1.73 | -2.10 | -0.94 |
| Year Ending Dec-14 | 7 | -0.03 | 3.28 | -2.28 | -1.10 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 9.69 | 7.60 | 2.08 | 21.51 |
| Quarter Ending Dec-12 | 10.41 | 12.73 | 2.32 | 22.25 |
| Quarter Ending Sep-12 | 16.48 | 5.10 | 11.37 | 69.04 |
| Quarter Ending Jun-12 | 18.99 | 21.86 | 2.87 | 15.11 |
| Quarter Ending Mar-12 | 40.51 | 24.23 | 16.28 | 40.19 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 8.59 | 8.65 | 8.81 | 9.12 | -- |
| Quarter Ending Dec-13 | 8.40 | 8.46 | 8.63 | 8.90 | -- |
| Year Ending Dec-13 | 32.81 | 32.53 | 32.96 | 33.56 | 67.50 |
| Year Ending Dec-14 | 145.75 | 55.75 | 56.18 | 56.35 | 66.09 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 1 | 0 | 2 |
| Quarter Ending Dec-13 | 0 | 1 | 0 | 2 |
| Year Ending Dec-13 | 1 | 0 | 1 | 1 |
| Year Ending Dec-14 | 4 | 0 | 4 | 0 |
| Earnings | ||||
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates